HBW
Hazlett, Burt & Watson’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Buy |
9,588
+111
| +1% | +$20.6K | 0.73% | 35 |
|
|
2025
Q1 | $1.99M | Buy |
9,477
+200
| +2% | +$41.9K | 0.89% | 21 |
|
|
2024
Q4 | $1.65M | Sell |
9,277
-139
| -1% | -$24.7K | 0.73% | 30 |
|
|
2024
Q3 | $1.86M | Buy |
9,416
+62
| +0.7% | +$12.2K | 0.85% | 23 |
|
|
2024
Q2 | $1.6M | Buy |
9,354
+4,144
| +80% | +$710K | 0.83% | 27 |
|
|
2024
Q1 | $947K | Buy |
5,210
+56
| +1% | +$10.2K | 0.57% | 35 |
|
|
2023
Q4 | $798K | Hold |
5,154
| – | – | 0.54% | 38 |
|
|
2023
Q3 | $769K | Buy |
5,154
+116
| +2% | +$17.3K | 0.57% | 31 |
|
|
2023
Q2 | $678K | Buy |
5,038
+5
| +0.1% | +$673 | 0.51% | 31 |
|
|
2023
Q1 | $802K | Buy |
5,033
+188
| +4% | +$30K | 0.66% | 27 |
|
|
2022
Q4 | $780K | Sell |
4,845
-235
| -5% | -$37.8K | 0.69% | 27 |
|
|
2022
Q3 | $682K | Buy |
5,080
+7
| +0.1% | +$940 | 0.66% | 32 |
|
|
2022
Q2 | $777K | Buy |
5,073
+6
| +0.1% | +$919 | 0.71% | 28 |
|
|
2022
Q1 | $822K | Buy |
+5,067
| New | +$822K | 0.65% | 31 |
|